BioStem Technologies, Inc. (OTC: BSEM) reported Q3 EPS of $0.03, $0.21 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $3.6 million versus the consensus estimate of $2.4 million.

For earnings history and earnings-related data on BioStem Technologies, Inc. (BSEM) click here.